semaglutide 2025 On February 21, 2025, the FDA announced that semaglutide, the active ingredient in Ozempic and Wegovy, is no longer considered in shortage, signaling an improvement in national supply. As a result, compounding Semaglutide in 2025: The Future

Ongoing Support These medications are adjustable, meaning we can change the dosage if youre experiencing side effects or youre not seeing results

International travel with semaglutide requires additional planning beyond domestic trips due to varying customs regulations, potential language barriers, and differences in medication availability

Human AD brain organoids treated with semaglutide similarly showed reduced A, phosphorylated tau, and GFAP expression (134)

Coverage varies based on your specific plan and clinical documentation

This is why blanket storage guidelines are helpful as starting points but should not replace peptide-specific knowledge